Publikationen in Zusammenarbeit mit Forschern von Fred Hutchinson Cancer Research Center (5)

2023

  1. Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial

    JAMA Network Open, Vol. 6, Núm. 4, pp. E235822

2021

  1. Pharmacologic control of homeostatic and antigen-driven proliferation to target HIV-1 persistence

    Biochemical Pharmacology, Vol. 194

  2. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

2019

  1. Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2–positive breast cancer

    European Journal of Cancer, Vol. 120, pp. 1-9

2009

  1. Acceptance and Commitment Therapy for Smoking Cessation: A Preliminary Study of Its Effectiveness in Comparison With Cognitive Behavioral Therapy

    Psychology of Addictive Behaviors, Vol. 23, Núm. 4, pp. 723-730